950 related articles for article (PubMed ID: 19383986)
1. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
[TBL] [Abstract][Full Text] [Related]
2. Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease.
Tefera S; Hatlebakk JG; Berstad A
Am J Gastroenterol; 2001 Apr; 96(4):969-74. PubMed ID: 11316213
[TBL] [Abstract][Full Text] [Related]
3. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
Leite LP; Johnston BT; Just RJ; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
[TBL] [Abstract][Full Text] [Related]
4. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
[TBL] [Abstract][Full Text] [Related]
6. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
Fiorucci S; Santucci L; Morelli A
Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
[TBL] [Abstract][Full Text] [Related]
7. Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus.
Fiorucci S; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1989 Oct; 84(10):1263-7. PubMed ID: 2801676
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
Weigt J; Kandulski A; Büsch F; Malfertheiner P
Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
[TBL] [Abstract][Full Text] [Related]
9. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
10. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
Omari TI; Haslam RR; Lundborg P; Davidson GP
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
[TBL] [Abstract][Full Text] [Related]
12. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors.
Peghini PL; Katz PO; Bracy NA; Castell DO
Am J Gastroenterol; 1998 May; 93(5):763-7. PubMed ID: 9625124
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic full-thickness plication (Plicator) with two serially placed implants improves esophagitis and reduces PPI use and esophageal acid exposure.
von Renteln D; Brey U; Riecken B; Caca K
Endoscopy; 2008 Mar; 40(3):173-8. PubMed ID: 18322871
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole as a diagnostic tool in gastroesophageal reflux disease.
Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Jansen EH; Tuynman HA; Schrijver M; Dieleman LA; Meuwissen SG
Am J Gastroenterol; 1997 Nov; 92(11):1997-2000. PubMed ID: 9362179
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the acidity index and integrated intragastric acidity in 645 patients presenting with gastroesophageal reflux disease symptoms.
Blonski WC; Shih GL; Brensinger CM; Katzka DA; Metz DC
Scand J Gastroenterol; 2006 Apr; 41(4):382-9. PubMed ID: 16635904
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
[TBL] [Abstract][Full Text] [Related]
17. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
Howden CW; Ballard ED; Koch FK; Gautille TC; Bagin RG
J Clin Gastroenterol; 2009 Apr; 43(4):323-6. PubMed ID: 18758373
[TBL] [Abstract][Full Text] [Related]
18. Dilated intercellular spaces in gastroesophageal reflux disease patients and the changes of intercellular spaces after omeprazole treatment.
Xue Y; Zhou LY; Lin SR
Chin Med J (Engl); 2008 Jul; 121(14):1297-301. PubMed ID: 18713551
[TBL] [Abstract][Full Text] [Related]
19. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
20. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
Milkes D; Gerson LB; Triadafilopoulos G
Am J Gastroenterol; 2004 Jun; 99(6):991-6. PubMed ID: 15180715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]